Skip to main content

English
Français

Breadcrumb

Help and support
I'm a healthcare provider

I'm a healthcare provider

Learn more about dementia and how you can ensure quality person-centred care for people living with the disease.

Share:

Share on Facebook
Share on Twitter
Share on LinkedIn
Print this page

What is aducanumab?

Aducanumab is the newest clinical treatment for Alzheimer’s disease in nearly two decades. A U.S. agency approved the drug in June 2021. A European Union agency refused the drug in December 2021. Drug-maker Biogen withdrew the drug from Health Canada review in June 2022.

Providing person-centred care

Fostering a person-centred approach to care will improve the quality of care for people with dementia and their families.

Person-centred care of people with dementia living in care homes

The Alzheimer Society of Canada looked for evidence-based research that shows how to successfully implement person-centred programs and practices in long-term care homes. Here is the result.

Diagnosis and screening

Tools for healthcare professionals to support dementia screening, assessment and early diagnosis.

First Link® for healthcare providers

Understand the First Link® program and know the steps to refer a person newly diagnosed with dementia to their local Alzheimer Society.

Addressing ambiguous loss and grief as a healthcare provider

Practical resources to help healthcare professionals understand loss and grief associated with dementia.

Professional development

A selection of training and e-learning modules as well as useful resources.

Other resources and tools for healthcare providers

Get resources on driving, pain, dementia research, self-management, long-term care and more.

Status message

Sorry… This form is closed to new submissions.

Leave this field blank

©2025 Alzheimer Society of Canada. All rights reserved.